SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-21-234940
Filing Date
2021-08-03
Accepted
2021-08-03 16:12:03
Documents
64
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q d194083d10q.htm   iXBRL 10-Q 1694383
2 EX-10.1 d194083dex101.htm EX-10.1 21117
3 EX-31.1 d194083dex311.htm EX-31.1 10647
4 EX-31.2 d194083dex312.htm EX-31.2 10649
5 EX-32.1 d194083dex321.htm EX-32.1 5846
11 GRAPHIC g194083g11i55.jpg GRAPHIC 3220
  Complete submission text file 0001193125-21-234940.txt   5982534

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA gbt-20210630.xsd EX-101.SCH 39209
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE gbt-20210630_cal.xml EX-101.CAL 44221
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE gbt-20210630_def.xml EX-101.DEF 186572
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE gbt-20210630_lab.xml EX-101.LAB 380823
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gbt-20210630_pre.xml EX-101.PRE 308829
12 EXTRACTED XBRL INSTANCE DOCUMENT d194083d10q_htm.xml XML 851956
Mailing Address 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080
Business Address 181 OYSTER POINT BLVD SOUTH SAN FRANCISCO CA 94080 650741-7700
Global Blood Therapeutics, Inc. (Filer) CIK: 0001629137 (see all company filings)

IRS No.: 274825712 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37539 | Film No.: 211139868
SIC: 2834 Pharmaceutical Preparations